Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study
- PMID: 35860452
- PMCID: PMC9289630
- DOI: 10.1016/j.eclinm.2022.101553
Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study
Abstract
Background: Liver disease is the only major chronic disease and mortality is increasing. Earlier detection of liver fibrosis can reduce progression to cirrhosis and hepatocellular carcinoma. Many studies have reported an increased prevalence in liver fibrosis among adults in urban regions but there are few data in physically active rural populations without attributable metabolic risk factors. This aim of this study is to investigate the prevalence of abnormal liver functions tests (LFTs) and liver fibrosis among adults in a rural population.
Methods: This cross-sectional study included observations from KMCH-NNCD-II (2017) study (n = 907) from a farming village, Nallampatti, located in South India. We assessed lifestyle (occupation, tobacco use and alcohol consumption using AUDIT-C questionnaire), markers for metabolic diseases (obesity, hypertension, diabetes, hypercholesterolemia), LFTs and markers for hepatitis viruses B and C. 901 participants had transient elastography to assess fibrosis. Participants with abnormal LFTs and significant liver fibrosis (F2-F4) underwent additional liver screening (caeruloplasmin, iron studies and autoimmune hepatitis panel). Multiple logistic regression analyses were performed to understand the association of liver fibrosis with lifestyle and metabolic risk factors after adjustment for co-variates.
Findings: Significant liver fibrosis (F2-F4) was observed in 14.4%, and cirrhosis in 0.8%. There was an association of liver fibrosis with abnormal LFTs but no association between alcohol consumption, viral hepatitis, hepatic liver screening and liver fibrosis. Among metabolic risk factors, no association was observed for hypertension and hypercholesterolemia but diabetes [OR - 3.206 (95% CI: 1.792 - 5.736)], obesity [1.987 (1.341 - 2.944)] and metabolic syndrome [2.539 (1.680 - 3.836)] showed association with significant liver fibrosis (F2-F4) after adjustment for confounding factors.
Interpretation: Our results suggest that the prevalence of liver fibrosis in rural population is similar to urban counterparts. The association of metabolic risk factors with liver fibrosis in physically active rural population warrants further investigations in future studies.
Funding: This study is funded by KMCH Research Foundation, India.
Keywords: Abnormal liver tests; Aetiological screening for abnormal LFT's; Elastography screening; Liver fibrosis; Low and middle income country; Metabolic syndrome; prevalence.
© 2022 The Author(s).
Conflict of interest statement
We declare no competing interests.
Figures
Similar articles
-
Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors.BMJ Open. 2020 Mar 31;10(3):e032890. doi: 10.1136/bmjopen-2019-032890. BMJ Open. 2020. PMID: 32234740 Free PMC article.
-
Differential risk factor profile of diabetes and atherosclerosis in rural, sub-urban and urban regions of South India: The KMCH-Non-communicable disease studies.Diabet Med. 2021 Jun;38(6):e14466. doi: 10.1111/dme.14466. Epub 2020 Dec 3. Diabet Med. 2021. PMID: 33236348
-
Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population.PLoS One. 2022 Feb 10;17(2):e0263768. doi: 10.1371/journal.pone.0263768. eCollection 2022. PLoS One. 2022. PMID: 35143562 Free PMC article.
-
Metals in urine in relation to the prevalence of pre-diabetes, diabetes and atherosclerosis in rural India.Occup Environ Med. 2018 Sep;75(9):661-667. doi: 10.1136/oemed-2018-104996. Epub 2018 Apr 19. Occup Environ Med. 2018. PMID: 29674487
-
Identification of liver disease: why and how.Frontline Gastroenterol. 2022 Jan 24;13(5):367-373. doi: 10.1136/flgastro-2021-101833. eCollection 2022. Frontline Gastroenterol. 2022. PMID: 36051960 Free PMC article. Review.
Cited by
-
Liver fibrosis and outcomes of atrial fibrillation: the FIB-4 index.Clin Res Cardiol. 2024 Feb;113(2):313-323. doi: 10.1007/s00392-023-02330-0. Epub 2023 Nov 27. Clin Res Cardiol. 2024. PMID: 38010520
-
Prevalence of Hepatic Steatosis and Fibrosis in Asian Indian Individuals with Type 2 Diabetes.Diabetes Ther. 2025 Sep;16(9):1797-1811. doi: 10.1007/s13300-025-01764-1. Epub 2025 Jul 3. Diabetes Ther. 2025. PMID: 40610807 Free PMC article.
-
Exploring the role of polysaccharides in mitigating organ damage caused by pesticide-induced toxicity: A systematic review and meta-analysis of in vivo studies.Narra J. 2025 Apr;5(1):e1553. doi: 10.52225/narra.v5i1.1553. Epub 2025 Feb 9. Narra J. 2025. PMID: 40352195 Free PMC article.
-
Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis.Clin Mol Hepatol. 2024 Sep;30(Suppl):S199-S213. doi: 10.3350/cmh.2024.0351. Epub 2024 Jul 30. Clin Mol Hepatol. 2024. PMID: 39074982 Free PMC article.
References
-
- Williams R, Ashton K, Aspinall R, et al. Implementation of the lancet standing commission on liver disease in the UK. Lancet. 2015;386(10008):2098–2111. - PubMed
-
- Harrison P, Hogan BJ, Floros L, Davies E, Guideline Development G. Assessment and management of cirrhosis in people older than 16 years: summary of NICE guidance. BMJ. 2016;354:i2850. - PubMed
-
- Gines P, Graupera I, Lammert F, et al. Screening for liver fibrosis in the general population: a call for action. Lancet Gastroenterol Hepatol. 2016;1(3):256–260. - PubMed
-
- Wilson JMG. World Health Organization; 1968. Jungner, Gunnar, World Health Organization. Principles and Practice of Screening for Disease /J. M. G. Wilson, G. Jungner.https://apps.who.int/iris/handle/10665/37650
-
- McLernon DJ, Donnan PT, Ryder S, et al. Health outcomes following liver function testing in primary care: a retrospective cohort study. Fam Pract. 2009;26(4):251–259. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous